Inhibition of immunothrombosis does not affect pathogen capture and does not promote bacterial dissemination in a mouse model of sepsis

References

• Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005;23(1):197–223. doi:10.1146/annurev.immunol.23.021704.115653.
   PubMedGoogle Scholar
• Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004;303(5663):1532–1535. doi:10.1126/science.1092385.
   PubMed Web of Science ®Google Scholar
• Zucoloto AZ, Jenne CN. Platelet-neutrophil interplay: insights into Neutrophil Extracellular Trap (NET)-driven coagulation in infection. Front Cardiovasc Med 2019;6(85). doi:10.3389/fcvm.2019.00085.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, Resink TJ. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett 2010;584(14):3193–3197. doi:10.1016/j.febslet.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012;7(2):e32366. doi:10.1371/journal.pone.0032366.
   PubMed Web of Science ®Google Scholar
• Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014;123(18):2768–2776. doi:10.1182/blood-2013-10-463646.
   PubMed Web of Science ®Google Scholar
• McDonald B, Davis RP, Kim S-J, Tse M, Esmon CT, Kolaczkowska E, Jenne CN. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood 2017;129(10):1357–1367. doi:10.1182/blood-2016-09-741298.
   PubMed Web of Science ®Google Scholar
• Lyons PG, Micek ST, Hampton N, Kollef MH. Sepsis-Associated coagulopathy severity predicts hospital mortality. Crit Care Med 2018;46(5):736–742. doi:10.1097/CCM.0000000000002997.
   PubMed Web of Science ®Google Scholar
• Chornenki NLJ, Hillis CM, Bence-Bruckler I, Busque L, Hamm C, Hasegawa W, Lipton JH, Savoie L, Turner R, Xenocostas A, et al. The predictive value of intracellular imatinib levels in chronic myeloid leukemia. Blood 2018;132(Suppl 1):4250. doi:10.1182/blood-2018-99-111294.
   Google Scholar
• Umemura Y, Yamakawa K, Hayakawa M, Hamasaki T, Fujimi S. Japan septic disseminated intravascular coagulation (J-Septic DIC) study group. Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: a nationwide multicenter registry in Japan. Thromb Res 2018;161(60–66). doi:10.1016/j.thromres.2017.11.023.
   PubMed Web of Science ®Google Scholar
• Levi M, Schultz M, van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost 2013;39(5):559–566. doi:10.1055/s-00000077.
   PubMed Web of Science ®Google Scholar
• Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res 2012;129(3):290–295. doi:10.1016/j.thromres.2011.10.013.
   PubMed Web of Science ®Google Scholar
• Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13(1):34–45. doi:10.1038/nri3345.
   PubMed Web of Science ®Google Scholar
• M-L VB, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Köllnberger M, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012;209(4):819–835. doi:10.1084/jem.20112322.
   PubMed Web of Science ®Google Scholar
• Grässle S, Huck V, Pappelbaum KI, Gorzelanny C, Aponte-Santamaría C, Baldauf C, Gräter F, Schneppenheim R, Obser T, Schneider SW. von Willebrand factor directly interacts with DNA from neutrophil extracellular traps. Arterioscler Thromb Vasc Biol 2014;34(7):1382–1389. doi:10.1161/ATVBAHA.113.303016.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med 2009;15(11):1318–1321. doi:10.1038/nm.2053.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 2011;187(5):2626–2631. doi:10.4049/jimmunol.1003930.
   PubMed Web of Science ®Google Scholar
• Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, Esmon CT. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011;118(7):1952–1961. doi:10.1182/blood-2011-03-343061.
   PubMed Web of Science ®Google Scholar
• Carestia A, Kaufman T, Rivadeneyra L, Landoni VI, Pozner RG, Negrotto S, D’Atri LP, Gómez RM, Schattner M. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol 2016;99(1):153–162. doi:10.1189/jlb.3A0415-161R.
   PubMed Web of Science ®Google Scholar
• Massberg S, Grahl L, M-L VB, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010;16(8):887–896. doi:10.1038/nm.2184.
   PubMed Web of Science ®Google Scholar
• Meier A, Chien J, Hobohm L, Patras KA, Nizet V, Corriden R. Inhibition of human Neutrophil Extracellular Trap (NET) production by propofol and lipid emulsion. Front Pharmacol 2019;10(323). doi:10.3389/fphar.2019.00323.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhao Y, Lai D, Zhang P, Yang Y, Li Y, Fei K, Jiang G, Fan J. Neutrophil extracellular traps promote macrophage pyroptosis in sepsis. Cell Death Dis 2018;9(6):597. doi:10.1038/s41419-018-0538-5.
   PubMedGoogle Scholar
• Urak KT, Blanco GN, Shubham S, Lin L-H, Dassie JP, Thiel WH, Chen Y, Sonkar VK, Lei B, Murthy S, et al. RNA inhibitors of nuclear proteins responsible for multiple organ dysfunction syndrome. Nat Commun 2019;10(1):116. doi:10.1038/s41467-018-08030-y.
   PubMedGoogle Scholar
• Beristain-Covarrubias N, Perez-Toledo M, Flores-Langarica A, Zuidscherwoude M, JR H, WM C, LDW K, Thomas MR, Henderson IR, Rayes J, et al. Salmonella-induced thrombi in mice develop asynchronously in the spleen and liver and are not effective bacterial traps. Blood 2019;133(6):600–604. doi:10.1182/blood-2018-08-867267.
   PubMed Web of Science ®Google Scholar
• Wong CHY, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol 2013;14(8):785–792. doi:10.1038/ni.2631.
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13(4):463–469. doi:10.1038/nm1565.
   PubMed Web of Science ®Google Scholar
• Shannon O. Platelet interaction with bacterial toxins and secreted products. Platelets 2015;26(4):302–308. doi:10.3109/09537104.2015.1014471.
   PubMed Web of Science ®Google Scholar
• Azzouz L, Cherry A, Riedl M, Khan M, Pluthero FG, Kahr WHA, Palaniyar N, Licht C. Relative antibacterial functions of complement and NETs: nETs trap and complement effectively kills bacteria. Mol Immunol 2018;97(71–81). doi:10.1016/j.molimm.2018.02.019.
   PubMed Web of Science ®Google Scholar
• Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, Claus RA, Bauer M, Lösche W. Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets 2009;20(1):50–57. doi:10.1080/09537100802503368.
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Wang Y, Liu B, Ma X, Ding R. Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis. J Crit Care 2019;50(162–168). doi:10.1016/j.jcrc.2018.12.004.
   PubMed Web of Science ®Google Scholar
• Eisen DP, Moore EM, Leder K, Lockery J, McBryde ES, McNeil JJ, Pilcher D, Wolfe R, Woods RL. AspiriN to inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol. BMJ Open 2017;7(1):e013636. doi:10.1136/bmjopen-2016-013636.
   PubMed Web of Science ®Google Scholar
• Eisen DP, Reid D, McBryde ES. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med 2012;40(6):1761–1767. doi:10.1097/CCM.0b013e318246b9df.
   PubMed Web of Science ®Google Scholar
• Otto GP, Sossdorf M, Boettel J, Kabisch B, Breuel H, Winning J, Lösche W. Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets 2013;24(6):480–485. doi:10.3109/09537104.2012.724482.
   PubMed Web of Science ®Google Scholar
• Lösche W, Boettel J, Kabisch B, Winning J, Claus RA, Do Aspirin BM. Other antiplatelet drugs reduce the mortality in critically ill patients? Thrombosis 2012;2012:1–8. doi:10.1155/2012/720254.
   Google Scholar